Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
Identifieur interne : 002038 ( Main/Exploration ); précédent : 002037; suivant : 002039Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
Auteurs : S. Paramothayan ; T. Lasserson ; E H WaltersSource :
- The Cochrane database of systematic reviews [ 1469-493X ] ; 2003.
Descripteurs français
- KwdFr :
- Antinéoplasiques (effets indésirables), Antinéoplasiques (usage thérapeutique), Chloroquine (usage thérapeutique), Ciclosporine (usage thérapeutique), Essais contrôlés randomisés comme sujet, Humains, Immunosuppresseurs (effets indésirables), Immunosuppresseurs (usage thérapeutique), Méthotrexate (usage thérapeutique), Sarcoïdose pulmonaire (traitement médicamenteux).
- MESH :
- effets indésirables : Antinéoplasiques, Immunosuppresseurs.
- traitement médicamenteux : Sarcoïdose pulmonaire.
- usage thérapeutique : Antinéoplasiques, Chloroquine, Ciclosporine, Immunosuppresseurs, Méthotrexate.
- Essais contrôlés randomisés comme sujet, Humains.
English descriptors
- KwdEn :
- Antineoplastic Agents (adverse effects), Antineoplastic Agents (therapeutic use), Chloroquine (therapeutic use), Cyclosporine (therapeutic use), Humans, Immunosuppressive Agents (adverse effects), Immunosuppressive Agents (therapeutic use), Methotrexate (therapeutic use), Randomized Controlled Trials as Topic, Sarcoidosis, Pulmonary (drug therapy).
- MESH :
- chemical , adverse effects : Antineoplastic Agents, Immunosuppressive Agents.
- chemical , therapeutic use : Antineoplastic Agents, Chloroquine, Cyclosporine, Immunosuppressive Agents, Methotrexate.
- drug therapy : Sarcoidosis, Pulmonary.
- Humans, Randomized Controlled Trials as Topic.
Abstract
Immunosuppressive and cytotoxic agents have been used as both an alternative to oral corticosteroids, and as a means of maintaining a low dose of steroids in the treatment of pulmonary sarcoidosis.
DOI: 10.1002/14651858.CD003536
PubMed: 12917971
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000462
- to stream PubMed, to step Curation: 000462
- to stream PubMed, to step Checkpoint: 000438
- to stream Ncbi, to step Merge: 000036
- to stream Ncbi, to step Curation: 000036
- to stream Ncbi, to step Checkpoint: 000036
- to stream Main, to step Merge: 002054
- to stream Main, to step Curation: 002038
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.</title><author><name sortKey="Paramothayan, S" sort="Paramothayan, S" uniqKey="Paramothayan S" first="S" last="Paramothayan">S. Paramothayan</name><affiliation><nlm:affiliation>Respiratory Medicine, Kingston Hospital NHS Trust, Galsworthy Rd, Kingston Upon Thames, Surrey, UK, KT2 7QB.</nlm:affiliation><wicri:noCountry code="subField">KT2 7QB</wicri:noCountry></affiliation></author><author><name sortKey="Lasserson, T" sort="Lasserson, T" uniqKey="Lasserson T" first="T" last="Lasserson">T. Lasserson</name></author><author><name sortKey="Walters, E H" sort="Walters, E H" uniqKey="Walters E" first="E H" last="Walters">E H Walters</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:12917971</idno><idno type="pmid">12917971</idno><idno type="doi">10.1002/14651858.CD003536</idno><idno type="wicri:Area/PubMed/Corpus">000462</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000462</idno><idno type="wicri:Area/PubMed/Curation">000462</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000462</idno><idno type="wicri:Area/PubMed/Checkpoint">000438</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000438</idno><idno type="wicri:Area/Ncbi/Merge">000036</idno><idno type="wicri:Area/Ncbi/Curation">000036</idno><idno type="wicri:Area/Ncbi/Checkpoint">000036</idno><idno type="wicri:Area/Main/Merge">002054</idno><idno type="wicri:Area/Main/Curation">002038</idno><idno type="wicri:Area/Main/Exploration">002038</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.</title><author><name sortKey="Paramothayan, S" sort="Paramothayan, S" uniqKey="Paramothayan S" first="S" last="Paramothayan">S. Paramothayan</name><affiliation><nlm:affiliation>Respiratory Medicine, Kingston Hospital NHS Trust, Galsworthy Rd, Kingston Upon Thames, Surrey, UK, KT2 7QB.</nlm:affiliation><wicri:noCountry code="subField">KT2 7QB</wicri:noCountry></affiliation></author><author><name sortKey="Lasserson, T" sort="Lasserson, T" uniqKey="Lasserson T" first="T" last="Lasserson">T. Lasserson</name></author><author><name sortKey="Walters, E H" sort="Walters, E H" uniqKey="Walters E" first="E H" last="Walters">E H Walters</name></author></analytic><series><title level="j">The Cochrane database of systematic reviews</title><idno type="eISSN">1469-493X</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents (adverse effects)</term><term>Antineoplastic Agents (therapeutic use)</term><term>Chloroquine (therapeutic use)</term><term>Cyclosporine (therapeutic use)</term><term>Humans</term><term>Immunosuppressive Agents (adverse effects)</term><term>Immunosuppressive Agents (therapeutic use)</term><term>Methotrexate (therapeutic use)</term><term>Randomized Controlled Trials as Topic</term><term>Sarcoidosis, Pulmonary (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antinéoplasiques (effets indésirables)</term><term>Antinéoplasiques (usage thérapeutique)</term><term>Chloroquine (usage thérapeutique)</term><term>Ciclosporine (usage thérapeutique)</term><term>Essais contrôlés randomisés comme sujet</term><term>Humains</term><term>Immunosuppresseurs (effets indésirables)</term><term>Immunosuppresseurs (usage thérapeutique)</term><term>Méthotrexate (usage thérapeutique)</term><term>Sarcoïdose pulmonaire (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term><term>Immunosuppressive Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents</term><term>Chloroquine</term><term>Cyclosporine</term><term>Immunosuppressive Agents</term><term>Methotrexate</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Sarcoidosis, Pulmonary</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term><term>Immunosuppresseurs</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Sarcoïdose pulmonaire</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques</term><term>Chloroquine</term><term>Ciclosporine</term><term>Immunosuppresseurs</term><term>Méthotrexate</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Randomized Controlled Trials as Topic</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Essais contrôlés randomisés comme sujet</term><term>Humains</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Immunosuppressive and cytotoxic agents have been used as both an alternative to oral corticosteroids, and as a means of maintaining a low dose of steroids in the treatment of pulmonary sarcoidosis.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Lasserson, T" sort="Lasserson, T" uniqKey="Lasserson T" first="T" last="Lasserson">T. Lasserson</name><name sortKey="Paramothayan, S" sort="Paramothayan, S" uniqKey="Paramothayan S" first="S" last="Paramothayan">S. Paramothayan</name><name sortKey="Walters, E H" sort="Walters, E H" uniqKey="Walters E" first="E H" last="Walters">E H Walters</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002038 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002038 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:12917971
|texte= Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:12917971" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |